Peter Attia· MD
So ketogenic diet, if you can stay on it, would be my recommendation if you have cancer and you're going on a PI3K inhibitor. Sodium glucose co-transporter inhibitor, however, is easier for most people to take.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So ketogenic diet, if you can stay on it, would be my recommendation if you have cancer and you're going on a PI3K inhibitor. Sodium glucose co-transporter inhibitor, however, is easier for most people to take.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
or another trial that we're starting now as a trial with sglt2 inhibitor plus a low carbohydrate but not fully ketogenic diet to see if it can put people in ketosis and then just looking forward to would this be a convenient way to get the benefits of ketosis in cancer patients while still allowing them to have a little bit of you know breaking bread with the family